Effectiveness versus convenience: Patient preferences for an erythropoietic agent to treat cancer-related anemia

Current Medical Research and Opinion

Volumn 23, Issue 1, 2007, Pages 85-92

  Langer, Corey J ^a   Fastenau, John M ^b   Forlenza, Jamie B ^b   Piech, Catherine Tak ^b   Bolge, Susan C ^c   Allen, Jennifer Gano ^c   Zilberberg, Marya D ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b Ortho Biotech Products LP   (United States)

^c Consumer Health Sciences ^*  (United States)

Author keywords

Cancer related anemia; Choice based conjoint analysis; Convenience; Effectiveness; Erythropoietic treatment agents; Patient preferences

Indexed keywords

ERYTHROPOIETIN; PLATINUM;

ACCURACY; ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEALTH PRACTITIONER; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL INFORMATION SYSTEM; QUESTIONNAIRE;

ANEMIA; CHI-SQUARE DISTRIBUTION; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SATISFACTION; QUESTIONNAIRES; TREATMENT OUTCOME; UNITED STATES;

EID: 33846692625     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X162728     Document Type: Article

References (31)

1. Pujade-Lauraine E, Gascon P. The burden of anaemia in patients with cancer. Oncology 2004;67(Suppl 1):1-4
2. Cella D, Dobrez D, Glaspy J. Control of cancer-related anemia with erythropoietic agents: A review of evidence for improved quality of life and clinical outcomes. Ann Oncol 2003;14:511-9
3. Morère JF. Role of epoetin in the management of anaemia in patients with lung cancer. Lung Cancer 2004;46:149-56
4. Stone P, Richards M, A'Hern R, et al. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 2000;11:561-7
5. Gillespie TW. Effects of cancer-related anemia on clinical and quality-of-life outcomes. Clin J Oncol Nurs 2002;6:1-6
6. Witzig TE, Silberstein PE, Loprinzi CL, et al. Phase II, randomized, double-blind study of epoetin alfa versus placebo in anemic patients with cancer undergoing chemotherapy. J Clin Oncol 2005;23:2606-17
7. Shasha D, George MJ, Harrison LB. Once weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy. Cancer 2003;98:1072-9
8. Cella D, Zagari MJ, Vandoros C, et al. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol 2003;21:366-73
9. Gabrilove JL, Cleeland CS, Livingston RB, et al. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 2001;19:2875-82
10. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 1999;1:1616-34
11. Demetri GD, Kris M, Wade J, et al. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. J Clin Oncol 1998;16:3412-25
12. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer 2001;84(Suppl 1):3-10
13. Macdougall IC. Optimizing the use or erythropoietic agents - pharmacokinetic and pharmacodynamic considerations. Nephrol Dial Transplant 2002;17(Suppl 5):66-70
14. Valley AW. Overview of cancer-related anemia: focus on the potential role of darbepoetin alfa. Pharmacotherapy 2002;22(Suppl 2):150-9S
15. Ryan M, Scott DA, Reeves C, et al: Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess 2001;5:1-186
16. Sawtooth Software, Inc. Choice-based conjoint (CBC) technical paper. Sequim, WA, 2001
17. Stewart M, Brown JB, Donner A. The impact of patient-centered care on patient outcomes. J Fam Pract 2000;49:796-804
18. Garrity TF. Medical compliance and the clinician-patient relationship. Soc Sci Med 1981;15:215-22
19. Krupat E, Bel RA, Kravitz RL, et al. When physicians and patients think alike: patient-centered beliefs and their impact on satisfaction and trust. J Fam Pract 2001;50:1057-62
20. Bokemeyer C, Foubert J. Anemia impact and management: focus on patient needs and the use of erythropoietic agents. Semin Oncol 2004;31(Suppl 8):4-11
21. Osoba D, Hsu M, Copley-Merriman C, et al. Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment. Qual Life Res 2006;15:273-83
22. Johnson FR, Hauber AB, Osoba D, et al. Are chemotherapy patients' HRQoL importance weights consistent with linear scoring rules? A stated-choice approach. Qual Life Res 2006;15:285-98
23. Rosberg J, Lefebvre P, Fastenau J, et al. Clinical significance of a ≥ 1 g/dL rise in hemoglobin at week 4 or at week 8 during epoetin alfa treatment (abstr). Blood 2003;102:510b
24. Sawtooth Software, Inc. Adaptive conjoint analysis (ACA) technical paper. Sequim, WA, 2002
25. Orme B. Which conjoint method should I use? Sawtooth Software, Inc. Research Paper Series. Sequim, WA, 2003
26. Best SJ, Krueger B, Hubbard C, et al. An assessment of the generalizability of internet surveys. Soc Sci Comput Rev 2001;19:131-45
27. Gillespie K, Andresen E, Boslaugh, S, Recktenwalk A. (In)consistency of preference ratings: results using three methods of preference elicitation. Inaugural American Society of Health Economists Conference, Madison, Wisconsin, June 4-8, 2006
28. Allan L, Hays H, Jensen N, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. Br Med J 2001;322:1154-8
29. Weinberg EG, Naya I. Treatment preferences of adolescent patients with asthma. Pediatr Allergy Immunol 2000;11:49-55
30. Johnson M, Guilford S, Libretto SE. Patients have treatment preferences: a multicentre, double-blind, crossover study comparing rabeprazole and omeprazole. Curr Med Res Opin 2002;18:303-10
31. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodological, and regulatory issues. Value Health 2004;7:204-15